Hepion Pharmaceuticals up 222% since insider purchases
- Insider
- Vincent S. LoPriore
- Role
- Executive Chairman
- Company
- Hepion Pharmaceuticals (HEPA)
- Transaction
- Buy
- Shares
- 10M
- Amount
- $500K
- Price per share
- $0.05
- Trade date
- Aug 3, 2026
- Filed
- Aug 12, 2026, 9 days after the trade
- Source
- SEC Form 4 ↗
Executive Chairman Vincent S. LoPriore bought 10M shares of Hepion Pharmaceuticals at $0.05 on August 3, 2026, a $500K purchase. At 11:30 ET on October 30, 2026 the stock traded at $0.19, 222% above the first close after the purchase.
Three other insiders, Sireesh Appajosyula, Michael J. Purcell and Gary S. Stetz, also disclosed purchases on August 3, 2026. The purchase was reported to the SEC on August 12, 2026, 9 days after the trade.
When it was filed, it was larger than each of the 16 earlier insider purchases of Hepion Pharmaceuticals in our records since 2020. No sales by Vincent S. LoPriore have been reported since.
HEPA +28.6% on the day, close Oct 30
Since purchase+222.0%$0.06 → $0.19 at 11:30 ET
Since filing+171.4%$0.07 on Aug 13 → $0.19
Purchase$500K10M shares on Aug 3, 2026
Days since purchase88No sales by this filer since
Price since the purchase
Daily close · USD+200%
+100%
+50%
0%
Aug 4 · first close $0.06Oct 30 · $0.19
PurchaseFirst close above +200%